HBW Insight Podcast: COVID-19 Holds Back European Consumer Health Majors In Q1

HBW Insight editors discuss the latest European consumer healthcare industry news. This week, Tom Gallen and David Ridley look at the Q1 financial results of four major Europe-based OTC players - GSK, Sanofi, Bayer and Reckitt - to analyse the impact that the coronavirus is still having on the region's consumer healthcare industry. An almost non-existent cough and cold season, due to lockdown measures, and last year's stockpiling of OTC drugs, have led to double-digit decreases in Q1 sales. A continuing trend for wellness and dietary supplements has offset some of the negative impacts of COVID-19, and, when the cough and cold season returns, points to a bright future for the European OTC market.